Nutex Health Inc.
NUTX
$131.90
-$3.58-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 216.49M | 151.68M | 267.80M | 243.99M | 211.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 216.49M | 151.68M | 267.80M | 243.99M | 211.79M |
| Cost of Revenue | 119.26M | 93.85M | 107.92M | 113.81M | 88.36M |
| Gross Profit | 97.22M | 57.83M | 159.88M | 130.17M | 123.43M |
| SG&A Expenses | 10.47M | -95.28M | 24.51M | 91.25M | 37.68M |
| Depreciation & Amortization | 5.49M | 5.19M | 5.00M | 5.25M | 5.09M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 135.22M | 3.76M | 137.44M | 210.31M | 131.13M |
| Operating Income | 81.27M | 147.92M | 130.37M | 33.68M | 80.66M |
| Income Before Tax | 76.56M | 25.89M | 123.94M | 23.73M | 71.22M |
| Income Tax Expenses | 13.80M | 9.29M | 27.14M | 7.59M | 20.41M |
| Earnings from Continuing Operations | 62.76M | 16.61M | 96.80M | 16.14M | 50.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.96M | -4.77M | -41.36M | -33.84M | -29.59M |
| Net Income | 46.81M | 11.83M | 55.44M | -17.70M | 21.22M |
| EBIT | 81.27M | 147.92M | 130.37M | 33.68M | 80.66M |
| EBITDA | 86.76M | 153.11M | 135.37M | 38.93M | 85.75M |
| EPS Basic | 6.70 | 1.67 | 8.27 | -2.95 | 3.74 |
| Normalized Basic EPS | 4.56 | 11.96 | 5.39 | -3.17 | 2.63 |
| EPS Diluted | 6.52 | 1.56 | 7.76 | -2.95 | 3.33 |
| Normalized Diluted EPS | 4.44 | 11.96 | 5.03 | -3.17 | 2.31 |
| Average Basic Shares Outstanding | 6.99M | 7.07M | 6.70M | 5.99M | 5.67M |
| Average Diluted Shares Outstanding | 7.18M | 7.07M | 7.18M | 5.99M | 6.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |